Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bower

Showing results (41-50 of 252) with videos related to

Pageof 26
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|May 8, 2010
Lymphoma in the immunocompromisedAilsa Sita-Lumsden, Philippa Harris, Mark Bower
AIDS (London, England)|May 5, 2017
Oncological challenges for an ageing population living with HIVAlessia Dalla Pria, Shairoz Merchant, Mark Bower
The Lancet. Oncology|November 4, 2004
Cardiotoxicity after liposomal anthracyclinesAnne Marie Young, Tony Dhillon, Mark Bower
Journal of HIV Therapy|June 22, 2007
The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphomaGail Clayton, Anita Omasta-Martin, Mark Bower
Expert Opinion on Biological Therapy|August 4, 2009
Immunotherapy for HIV-associated non-Hodgkin's lymphomaThomas Newsom-Davis, Eliyaz Ahamed, Mark Bower
Clinical Lymphoma|October 15, 2003
Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapyChristina Thirlwell, Debashis Sarker, Justin Stebbing, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
The rationale and development of new drugs to treat HIV infectionJustin Stebbing, Eleftheria Hatzimichael, Mark Bower, et al.
European Journal of Haematology|October 6, 2009
Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)-latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T-cell responseHesham El-Daly, Mark Bower, Kikkeri N Naresh
Journal of HIV Therapy|October 27, 2007
HIV-associated renal cell cancerF Hulbert, A Ozzard, M Tuthill, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 25, 2006
Significance of variation within HIV, EBV, and KSHV subtypesJustin Stebbing, Tom Powles, Mark Nelson, et al.
Pageof 26

Showing results (41-50 of 252) with videos related to

Sort By:
Pageof 26
British Journal of Hospital Medicine (London, England : 2005)|May 8, 2010
Lymphoma in the immunocompromisedAilsa Sita-Lumsden, Philippa Harris, Mark Bower
AIDS (London, England)|May 5, 2017
Oncological challenges for an ageing population living with HIVAlessia Dalla Pria, Shairoz Merchant, Mark Bower
The Lancet. Oncology|November 4, 2004
Cardiotoxicity after liposomal anthracyclinesAnne Marie Young, Tony Dhillon, Mark Bower
Journal of HIV Therapy|June 22, 2007
The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphomaGail Clayton, Anita Omasta-Martin, Mark Bower
Expert Opinion on Biological Therapy|August 4, 2009
Immunotherapy for HIV-associated non-Hodgkin's lymphomaThomas Newsom-Davis, Eliyaz Ahamed, Mark Bower
Clinical Lymphoma|October 15, 2003
Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapyChristina Thirlwell, Debashis Sarker, Justin Stebbing, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
The rationale and development of new drugs to treat HIV infectionJustin Stebbing, Eleftheria Hatzimichael, Mark Bower, et al.
European Journal of Haematology|October 6, 2009
Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)-latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T-cell responseHesham El-Daly, Mark Bower, Kikkeri N Naresh
Journal of HIV Therapy|October 27, 2007
HIV-associated renal cell cancerF Hulbert, A Ozzard, M Tuthill, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 25, 2006
Significance of variation within HIV, EBV, and KSHV subtypesJustin Stebbing, Tom Powles, Mark Nelson, et al.
Pageof 26